# IDIQ for the purchase of human induced pluripotent stem cell-derived cells

Canonical: https://abierto.us/opportunities/fdass126983

- Solicitation number: FDASS126983
- Notice type: Solicitation
- Status: Closed. Deadline was May 2, 2025 at 10:00 AM EDT
- Department: Department of Health and Human Services
- Agency: Food and Drug Administration
- Contracting office: FDA Center for Drug Evaluation and Research (75DKKN)
- NAICS: 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Product or service code: B529 Scientific Data Studies
- Set-aside: 8(a) sole source
- First posted: April 9, 2025
- Last posted: April 9, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/4a54b7666e5c4f5386a618d79860369e/view

## Description

**Notice of Intent to Sole Source Solicitation Number:**

**FDA - Sole Source - 126983 Posted Date:**

**April 09, 2025 Questions Due Date:**

**10AM EST on April 21, 2025 Response Date:**

**10AM EST May 02, 2025 NAICS Code:** 541714-Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

## Publications

- April 9, 2025: Solicitation, due May 2, 2025 at 10:00 AM EDT. Notice 4a54b7666e5c4f5386a618d79860369e. https://sam.gov/workspace/contract/opp/4a54b7666e5c4f5386a618d79860369e/view

## Points of contact

- Telisha Wilson, telisha.wilson@fda.hhs.gov

---
Source: SAM.gov Contract Opportunities bulk extract. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/fdass126983.